Member Directory

Patrys Ltd

Member Contact: James Campbell

Position: Chief Executive Officer

Industry: Biotech & Pharmaceuticals

Company Profile:

Based in Melbourne, Australia, Patrys (ASX: PAB) is a drug development company focused on developing and commercialising therapeutic antibodies. Patrys has a novel suite of deoxymab antibodies which are progressing through development as therapies for a range of different cancers. Deoxymabs have a novel mechanism of action, being able to enter cancer cell nuclei and inhibit DNA repair and replication. Deoxymabs can also cross the blood brain barrier making them suitable for a range of ADC and AOC programs that exploit the unique attributes of these assets. Patrys is advancing two lead candidates towards the market, and welcomes partnering discussions with interested parties.

For further information on Patrys, visit www.patrys.com

Home

News & opinion

Events

CLICK HERE TO SUBSCRIBE TO OUR NEWSLETTER

BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.

We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.